Why the study?
Does lidocaine or transvenous pacing prevent ventricular tachycardia and fibrillation in patients with acute myocardial infarction and premature ventricular beats?
Does lidocaine or transvenous pacing prevent ventricular tachycardia and fibrillation in patients with acute myocardial infarction and premature ventricular beats?
Lidocaine and transvenous pacing are highlighted as key treatments for premature ventricular beats in acute myocardial infarction to prevent life-threatening arrhythmias.
May support lidocaine for PVCs in AMI; leaves open whether it prevents VT/VF versus modern therapies.
Premature ventricular beats are very common in acute myocardial infarction. This arrhythmia requires immediate and aggressive treatment because it is the forerunner of ventricular tachycardia and fibrillation. The treatment of choice is lidocaine, usually in an initial dose of 50 to 100 mg intravenously. Atrial and ventricular transvenous pacing have been effective in overdriving and preventing cases of drug-resistant ventricular arrhythmias.
No takes yet. Share an insight, caveat, or question.
Peter C. Gazes (1970) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: